alendronate has been researched along with jaw in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (25.00) | 29.6817 |
2010's | 6 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Mehrotra, B; Ruggiero, SL | 1 |
Beirne, JC; Khosa, AD; Nayyar, MS | 1 |
Eufinger, H; Hoefert, S; Schmitz, I; Tannapfel, A | 1 |
Azambuja, AA; Campos, MM; Cherubini, K; Maahs, MP; Salum, FG | 1 |
Grey, A | 1 |
Cheung, A; Seeman, E | 1 |
Andrade, CR; Conte Neto, N; Guimarães, M; Marcantonio, E; S Bastos, A; Spolidorio, LC | 1 |
Costela-Ruiz, VJ; García-Martínez, O; Illescas-Montes, R; Manzano-Moreno, FJ; Melguizo-Rodriguez, L; Ramos-Torrecillas, J; Ruiz, C | 1 |
1 review(s) available for alendronate and jaw
Article | Year |
---|---|
Osteochemonecrosis of jaws and bisphosphonates.
Topics: Alendronate; Bone Density Conservation Agents; Etidronic Acid; Humans; Jaw; Osteonecrosis; Osteoporosis; Risedronic Acid; Risk Factors | 2007 |
7 other study(ies) available for alendronate and jaw
Article | Year |
---|---|
Ten years of alendronate treatment for osteoporosis in postmenopausal women.
Topics: Alendronate; Bone Regeneration; Female; Humans; Jaw; Osteonecrosis; Osteoporosis, Postmenopausal; Risk Factors | 2004 |
Importance of microcracks in etiology of bisphosphonate-related osteonecrosis of the jaw: a possible pathogenetic model of symptomatic and non-symptomatic osteonecrosis of the jaw based on scanning electron microscopy findings.
Topics: Adult; Aged; Aged, 80 and over; Alendronate; Bone Density Conservation Agents; Connective Tissue; Diphosphonates; Female; Humans; Imidazoles; Inflammation; Jaw; Jaw Diseases; Male; Mandibular Diseases; Maxillary Diseases; Microscopy, Electron, Scanning; Middle Aged; Osteomyelitis; Osteonecrosis; Osteoporosis; Osteoradionecrosis; Pamidronate; Time Factors; Zoledronic Acid | 2010 |
Association between bisphosphonates and jaw osteonecrosis: a study in Wistar rats.
Topics: Alendronate; Animals; Bone Density Conservation Agents; Diphosphonates; Disease Models, Animal; Drug Therapy, Combination; Imidazoles; Jaw; Osteonecrosis; Random Allocation; Rats; Rats, Wistar; Tooth Extraction; Zoledronic Acid | 2011 |
Teriparatide for bone loss in the jaw.
Topics: Alendronate; Bone Density Conservation Agents; Bone Regeneration; Combined Modality Therapy; Humans; Jaw; Jaw Diseases; Osteonecrosis; Periodontitis; Teriparatide | 2010 |
Teriparatide therapy for alendronate-associated osteonecrosis of the jaw.
Topics: Aged, 80 and over; Alendronate; Bone Density Conservation Agents; Bone Regeneration; Female; Humans; Jaw; Jaw Diseases; Osteonecrosis; Radiography; Teriparatide | 2010 |
Experimental development of bisphosphonate-related osteonecrosis of the jaws in rodents.
Topics: Alendronate; Alkaline Phosphatase; Animals; Biomarkers; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Remodeling; Collagen Type I; Disease Models, Animal; Jaw; Male; Molar; Orthognathic Surgical Procedures; Peptides; Rats; Time Factors; Tooth Extraction; Weight Gain | 2013 |
Impact of bisphosphonates on the proliferation and gene expression of human fibroblasts.
Topics: Alendronate; Bisphosphonate-Associated Osteonecrosis of the Jaw; Cell Differentiation; Cell Proliferation; Diphosphonates; Fibroblasts; Gene Expression Regulation; Humans; Ibandronic Acid; Jaw; Osteoblasts; Real-Time Polymerase Chain Reaction; Zoledronic Acid | 2019 |